| Particulars (Rupees in Crores.) | Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 |
|---|---|---|---|---|---|
Gross Sales | 24,047.4 | 20,833.4 | 18,291.1 | 16,002.3 | 14,243.8 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 24,047.4 | 20,833.4 | 18,291.1 | 16,002.3 | 14,243.8 |
Other Operating Income | 68.1 | 63.9 | 63.5 | 68 | 35.5 |
Other Income | 631.8 | 709.6 | 946.3 | 429 | 238.9 |
Total Income | 24,747.3 | 21,606.9 | 19,300.9 | 16,499.3 | 14,518.2 |
Total Expenditure | 17,606.8 | 14,797 | 13,539.5 | 12,760.3 | 11,462.6 |
PBIDT | 7,140.5 | 6,809.9 | 5,761.4 | 3,739 | 3,055.6 |
Interest | 217.2 | 111.8 | 107.4 | 64.3 | 67.3 |
PBDT | 6,923.3 | 6,698.1 | 5,654 | 3,674.7 | 2,988.3 |
Depreciation | 1,249 | 1,102.3 | 934.7 | 872.2 | 920 |
Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 |
Tax | 1,825.8 | 1,663.6 | 386.5 | 494.9 | 679.2 |
Deferred Tax | -290 | -335.9 | 785.7 | 222.1 | -5.2 |
Reported Profit After Tax | 4,138.5 | 4,268.1 | 3,547.1 | 2,085.5 | 1,394.3 |
Minority Interest After NP | 76.7 | 0 | 0 | 0 | 0 |
Net Profit after Minority Interest | 4,061.8 | 4,268.1 | 3,547.1 | 2,085.5 | 1,394.3 |
Extra-ordinary Items | 0 | 0 | 0 | 0 | 0 |
Adjusted Profit After Extra-ordinary item | 4,061.8 | 4,268.1 | 3,547.1 | 2,085.5 | 1,394.3 |
EPS (Unit Curr.) | 48.77 | 256.57 | 213.68 | 125.74 | 84.07 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 |
Dividend (%) | 0 | 0 | 0 | 0 | 0 |
Equity | 83.4 | 83.4 | 83.3 | 83.2 | 83.1 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
PBIDTM(%) | 29.69 | 32.68 | 31.49 | 23.36 | 21.45 |
PBDTM(%) | 28.79 | 32.15 | 30.91 | 22.96 | 20.97 |
PATM(%) | 17.2 | 20.48 | 19.39 | 13.03 | 9.78 |
Senores Pharmaceuticals intends to fund the acquisition through proceeds from its IPO, which raised ₹5.82 billion in December.
Here are some of the stocks that may see significant price movement today: KPI Green, Tata Power, UltraTech Cement, etc.
Dr Reddy's Laboratories third quarter net profit rose 2.5% year-on-year (YoY) to ₹1,413.3 crore.
The company logged a growth of 15.9% in its revenue from operations at ₹8,358.60 Crore versus ₹7,215 Crore in Q3FY24.
Here are some of the stocks that may see significant price movement today: Indus Towers, Dr Reddy’s Laboratories, Mankind Pharma, etc.
Here are some of the stocks that may see significant price movement today: Dr Reddy’s Laboratories, RITES, Canara Bank, etc.
Dr Reddy's already signed a license and commercialisation deal for Toripalimab with Shanghai Junshi Biosciences Co. Ltd in 2023.
Dr Reddy’s Laboratories shares has gained a total of 5.62% in the last one year, and 2.45% since the beginning of the year.
Here are some of the stocks that may see significant price movement today: UPL, Tata Power, JSW Steel, Dr Reddy’s, etc.
EBITDA for the quarter increased 5% year-on-year to ₹2,280 Crore between July and September 2024, while margins improved modestly to 28.4%.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
